GSWM
ABMD

Golden State Wealth Management’s Abiomed Inc ABMD Stock Holding History

Golden State Wealth Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-925
Closed -$134K – 982
2020
Q1 		$134K Buy
+925
New +$154K 0.06% 214

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Golden State Wealth Management's ABMD Position: Q2 2020 in Review

Golden State Wealth Management sold out of Abiomed Inc (ABMD) in Q2 2020, closing a stake of 925 shares — an estimated $134K sold.

Golden State Wealth Management first reported a position in ABMD in Q1 2020 and held it in 1 quarter. The position peaked at $134K in Q1 2020. 460 funds tracked by Wall St. Rank hold ABMD as of Q2 2020.

  • Golden State Wealth Management reported no remaining Abiomed Inc position as of Q2 2020 after selling out during the quarter.
  • Golden State Wealth Management sold 925 Abiomed Inc shares in Q2 2020, an estimated $134K.
  • Golden State Wealth Management first reported a position in Abiomed Inc in Q1 2020 and held it in 1 quarter.
  • Golden State Wealth Management's Abiomed Inc position peaked at $134K in Q1 2020.
  • 460 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2020.

Based on Golden State Wealth Management's 13F filing for Q2 2020, filed 11 Aug 2020.